BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

935 related articles for article (PubMed ID: 19712132)

  • 1. Primary urothelial carcinoma of the upper tract: important clinicopathological factors predicting bladder recurrence after surgical resection.
    Huang WW; Huang HY; Liao AC; Shiue YL; Tai HL; Lin CM; Wang YH; Lin CN; Shen KH; Li CF
    Pathol Int; 2009 Sep; 59(9):642-9. PubMed ID: 19712132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endoscopic management of upper tract urothelial carcinoma in patients with a history of bladder urothelial carcinoma.
    Krambeck AE; Thompson RH; Lohse CM; Patterson DE; Segura JW; Zincke H; Elliott DS; Blute ML
    J Urol; 2007 May; 177(5):1721-6. PubMed ID: 17437796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bladder cancer after nephroureterectomy in patients with urothelial carcinoma of the upper urinary tract.
    Ku JH; Choi WS; Kwak C; Kim HH
    Urol Oncol; 2011; 29(4):383-7. PubMed ID: 19556154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative study of oncologic outcome of laparoscopic nephroureterectomy and standard nephroureterectomy for upper urinary tract transitional cell carcinoma.
    Manabe D; Saika T; Ebara S; Uehara S; Nagai A; Fujita R; Irie S; Yamada D; Tsushima T; Nasu Y; Kumon H;
    Urology; 2007 Mar; 69(3):457-61. PubMed ID: 17382144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathologic features of bladder tumors after nephroureterectomy or segmental ureterectomy for upper urinary tract transitional cell carcinoma.
    Raman JD; Sosa RE; Vaughan ED; Scherr DS
    Urology; 2007 Feb; 69(2):251-4. PubMed ID: 17320658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive factors for bladder recurrence after radical nephroureterectomy for upper urinary tract urothelial carcinoma.
    Cho DS; Kim SI; Ahn HS; Kim SJ
    Urol Int; 2013; 91(2):153-9. PubMed ID: 23391941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CKD as a risk factor for bladder recurrence after nephroureterectomy for upper urinary tract urothelial carcinoma.
    Chung SD; Huang KH; Lai MK; Huang CY; Chen CH; Pu YS; Yu HJ; Chueh SC
    Am J Kidney Dis; 2007 Nov; 50(5):743-53. PubMed ID: 17954287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for intravesical recurrence following urothelial carcinoma of the upper urinary tract: no relationship to the mode of surgery.
    Koda S; Mita K; Shigeta M; Usui T
    Jpn J Clin Oncol; 2007 Apr; 37(4):296-301. PubMed ID: 17513309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of diagnostic ureteroscopy on intravesical recurrence and survival in patients with urothelial carcinoma of the upper urinary tract.
    Ishikawa S; Abe T; Shinohara N; Harabayashi T; Sazawa A; Maruyama S; Kubota K; Matsuno Y; Osawa T; Shinno Y; Kumagai A; Togashi M; Matsuda H; Mori T; Nonomura K
    J Urol; 2010 Sep; 184(3):883-7. PubMed ID: 20643446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of oncologic outcomes for open and laparoscopic nephroureterectomy: a multi-institutional analysis of 1249 cases.
    Capitanio U; Shariat SF; Isbarn H; Weizer A; Remzi M; Roscigno M; Kikuchi E; Raman JD; Bolenz C; Bensalah K; Koppie TM; Kassouf W; Fernández MI; Ströbel P; Wheat J; Zigeuner R; Langner C; Waldert M; Oya M; Guo CC; Ng C; Montorsi F; Wood CG; Margulis V; Karakiewicz PI
    Eur Urol; 2009 Jul; 56(1):1-9. PubMed ID: 19361911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bladder tumour development after urothelial carcinoma of the upper urinary tract is related to primary tumour location.
    Zigeuner RE; Hutterer G; Chromecki T; Rehak P; Langner C
    BJU Int; 2006 Dec; 98(6):1181-6. PubMed ID: 17125475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for intravesical recurrence after surgical management of transitional cell carcinoma of the upper urinary tract.
    Terakawa T; Miyake H; Muramaki M; Takenaka A; Hara I; Fujisawa M
    Urology; 2008 Jan; 71(1):123-7. PubMed ID: 18242379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphovascular invasion is independently associated with poor prognosis in patients with localized upper urinary tract urothelial carcinoma treated surgically.
    Saito K; Kawakami S; Fujii Y; Sakura M; Masuda H; Kihara K
    J Urol; 2007 Dec; 178(6):2291-6; discussion 2296. PubMed ID: 17936818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Independent prognostic factors for initial intravesical recurrence after laparoscopic nephroureterectomy for upper urinary tract urothelial carcinoma.
    Liu Y; Lu J; Hong K; Huang Y; Ma L
    Urol Oncol; 2014 Feb; 32(2):146-52. PubMed ID: 23628312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathological characteristics and clinical course of bladder tumour developing after nephroureterectomy.
    Abe T; Shinohara N; Harabayashi T; Sazawa A; Akino T; Ishikawa S; Kubota K; Matsuno Y; Osawa T; Shibata T; Toyoda Y; Shinno Y; Kamota S; Minami K; Sakashita S; Kumagai A; Takada N; Togashi M; Sano H; Mori T; Nonomura K
    BJU Int; 2010 Apr; 105(8):1102-6. PubMed ID: 19725822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavior of urothelial carcinoma with respect to anatomical location.
    Catto JW; Yates DR; Rehman I; Azzouzi AR; Patterson J; Sibony M; Cussenot O; Hamdy FC
    J Urol; 2007 May; 177(5):1715-20. PubMed ID: 17437794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary urothelial carcinoma of the upper urinary tract in dialysis patients with 5-year follow-up.
    Kang CH; Chen CH; Chiang PH
    Jpn J Clin Oncol; 2010 Mar; 40(3):241-6. PubMed ID: 19933687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significant predictive factors for prognosis of primary upper urinary tract cancer after radical nephroureterectomy in Taiwanese patients.
    Li CC; Chang TH; Wu WJ; Ke HL; Huang SP; Tsai PC; Chang SJ; Shen JT; Chou YH; Huang CH
    Eur Urol; 2008 Nov; 54(5):1127-34. PubMed ID: 18243511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The oncological results of laparoscopic nephroureterectomy for upper urinary tract transitional cell cancer are equal to those of open nephroureterectomy.
    Waldert M; Remzi M; Klingler HC; Mueller L; Marberger M
    BJU Int; 2009 Jan; 103(1):66-70. PubMed ID: 18710438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant methotrexate, vinblastine, adriamycin, and cisplatin chemotherapy has potential to prevent recurrence of bladder tumors after surgical removal of upper urinary tract transitional cell carcinoma.
    Soga N; Arima K; Sugimura Y
    Int J Urol; 2008 Sep; 15(9):800-3. PubMed ID: 18651862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.